The features of skin inflammation induced by lupus serum

Copyright © 2016 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 165(2016) vom: 24. Apr., Seite 4-11
Auteur principal: Liu, Lena (Auteur)
Autres auteurs: Xu, Guangqion, Dou, Hui, Deng, Guo-Min
Format: Article en ligne
Langue:English
Publié: 2016
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't IgG Lupus serum Skin inflammation Systemic lupus erythematosus Autoantibodies Cytokines Immune Sera Immunoglobulin G
Description
Résumé:Copyright © 2016 Elsevier Inc. All rights reserved.
We recently developed a model of lupus serum-induced skin inflammation, which was used to study the pathogenesis of skin injury in systemic lupus erythematosus (SLE). We further characterized the features of lupus serum-induced skin inflammation. This skin inflammation was evident within 3h and lasted for at least two weeks. The skin inflammation was characterized by an influx of monocytic, CD11b+cells and by a scarcity of T and B lymphocytes. Depletion of IgG from the serum abrogated the skin inflammatory response. The skin inflammation was related to lupus patients' skin history but not to SLE disease activity and type of autoantibody. The expression of TNFR1, NF-kB and MCP-1 was increased locally in skin lesions. The TLR9 ligand and lupus serum act synergistically to trigger skin inflammation. These findings suggest that this novel model is valuable for the study of the pathogenesis and therapy of skin injury in SLE
Description:Date Completed 31.08.2016
Date Revised 19.04.2016
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2016.02.007